IS REDUCING OVARIAN VOLUME IN POLYCYSTIC OVARIAN SYNDROME PATIENTS AFTER ADMINISTRATION OF METFORMIN ASSOCIATED WITH IMPROVING CARDIOVASCULAR RISK FACTORS?

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

GHARAKHANI MOHSEN; NEGHAB NOSRAT; FARIMANI MARZIE

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: International Journal of Fertility & Sterility Year:2011 | Volume:5 | Issue:2 Page(s): 90-95

Download Full-Text

View:

317

Download:

122

Cites:

Information Journal Paper

Title

IS REDUCING OVARIAN VOLUME IN POLYCYSTIC OVARIAN SYNDROME PATIENTS AFTER ADMINISTRATION OF METFORMIN ASSOCIATED WITH IMPROVING CARDIOVASCULAR RISK FACTORS?

Author(s)

GHARAKHANI MOHSEN | NEGHAB NOSRAT | FARIMANI MARZIE | Issue Writer Certificate

Keywords

POLYCYSTIC OVARIAN SYNDROME

METFORMIN

METABOLIC SYNDROME

Abstract

Background: Women with polycystic ovary syndrome (PCOS) are at increased risk for cardiovascular (CV) and metabolic disorders. There is a close relationship between elevated androgen plasma levels and the ultrasound findings of stromal hypertrophy. In randomized trials, the administration of METFORMIN has been shown to be followed by an improvement in insulin sensitivity and decrease in androgen levels in most women. In the present study, we investigate the association between reduced ovarian volume in PCOS patients after administration of METFORMIN with improvement in CV risk factors.Materials and Methods: This was a randomized clinical trial study. A total of 28 women diagnosed with PCOS who referred to the infertility clinic were selected. Anthropometric characteristics of the patients, mean ovarian volume and plasma levels of fasting blood sugar (FBS), lipid profile, luteinizing hormone (LH), follicle stimulating hormone (FSH), estradiol, testosterone, 17-a-OH progesterone (17OHP), dehydroepiandrosterone sulfate (DHEAS), C-reactive protein (CRP) and homocysteine (Hcy) were evaluated before and after treatment with 500 mg METFORMIN, three times daily for three months. Statistics were calculated with the aid of SPSS 16.0 with student’s paired t- and Pearson’s correlation coefficient tests. Significance was set at p<0.05.Results: There were significant reductions in mean ovarian volume and body mass index (BMI), in addition to CRP, Hcy, testosterone, FBS, HDL and LDL levels. There was a positive correlation between mean ovarian volume and waist-to-hip ratio (WHR). After treatment, there correlation noted with reduction in mean ovarian volume and decreased BMI, in addition to reductions in CRP, LDL, Hcy and testosterone levels.Conclusion: A positive correlation may exist between reduced mean ovarian volume and improvement in CV risk factors after administration of METFORMIN.

Cites

References

No record.

Cite

APA: Copy

GHARAKHANI, MOHSEN, NEGHAB, NOSRAT, & FARIMANI, MARZIE. (2011). IS REDUCING OVARIAN VOLUME IN POLYCYSTIC OVARIAN SYNDROME PATIENTS AFTER ADMINISTRATION OF METFORMIN ASSOCIATED WITH IMPROVING CARDIOVASCULAR RISK FACTORS?. INTERNATIONAL JOURNAL OF FERTILITY AND STERILITY, 5(2), 90-95. SID. https://sid.ir/paper/304964/en

Vancouver: Copy

GHARAKHANI MOHSEN, NEGHAB NOSRAT, FARIMANI MARZIE. IS REDUCING OVARIAN VOLUME IN POLYCYSTIC OVARIAN SYNDROME PATIENTS AFTER ADMINISTRATION OF METFORMIN ASSOCIATED WITH IMPROVING CARDIOVASCULAR RISK FACTORS?. INTERNATIONAL JOURNAL OF FERTILITY AND STERILITY[Internet]. 2011;5(2):90-95. Available from: https://sid.ir/paper/304964/en

IEEE: Copy

MOHSEN GHARAKHANI, NOSRAT NEGHAB, and MARZIE FARIMANI, “IS REDUCING OVARIAN VOLUME IN POLYCYSTIC OVARIAN SYNDROME PATIENTS AFTER ADMINISTRATION OF METFORMIN ASSOCIATED WITH IMPROVING CARDIOVASCULAR RISK FACTORS?,” INTERNATIONAL JOURNAL OF FERTILITY AND STERILITY, vol. 5, no. 2, pp. 90–95, 2011, [Online]. Available: https://sid.ir/paper/304964/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops